Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose oral estradiol for prevention of postmenopausal osteoporosis
2004-000811-24Phase 2Completed
- Sponsor
- Schering AG
- Start
- Oct 2004
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of estradiol in osteoporosis (3 arms), sponsored by Schering AG. Primary endpoint: Percent change in lumbar spine bone mineral density. Started Oct 2004; status: completed.
02
Drugs
estradiol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2004-000811-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000811-24.